Examples of using Combination with ipilimumab in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Severe infusion reactions have been reported in clinical trials of nivolumab or nivolumab in combination with ipilimumab see section 4.8.
Melanoma combination(with ipilimumab): studies CA209038,
OPDIVO as monotherapy or in combination with ipilimumab is indicated for the treatment of advanced(unresectable
When nivolumab is administered in combination with ipilimumab, refer to the Summary of Product Characteristics for ipilimumab prior to initiation of treatment.
An additional study in 945 previously untreated advanced melanoma patients investigated Opdivo in combination with ipilimumab, Opdivo used alone
Nivolumab or nivolumab in combination with ipilimumab must be permanently discontinued for severe(Grade 3) or life-threatening(Grade 4) adrenal insufficiency.
Severe rash has been observed with nivolumab in combination with ipilimumab and, less commonly,
Nivolumab or nivolumab in combination with ipilimumab should not be resumed while the patient is receiving immunosuppressive doses of corticosteroids or other immunosuppressive therapy.
Severe pneumonitis or interstitial lung disease, including fatal cases, has been observed with nivolumab monotherapy or nivolumab in combination with ipilimumab see section 4.8.
In the pooled dataset of nivolumab in combination with ipilimumab in melanoma(CA209067(combination group), CA209069, and CA209004-cohort 8),
A total of 945 patients were randomised to receive nivolumab in combination with ipilimumab(n 314),
the nivolumab or nivolumab in combination with ipilimumab infusion must be discontinued and appropriate medical therapy administered.
OPDIVO in combination with ipilimumab: The geometric mean CL,
Across clinical trials of nivolumab in combination with ipilimumab, the following additional clinically significant, immune-related adverse reactions were
for patients treated with nivolumab in combination with ipilimumab(n=448) are presented in Table 2.
When OPDIVO is given in combination with ipilimumab the recommended dose of OPDIVO is 1 mg of nivolumab per kilogram of your body weight for the first 4 doses combination phase.
Among the patients treated with nivolumab in combination with ipilimumab in CA209067, 151/313(48%) had the first
Patients with mild or moderate infusion reaction may receive nivolumab or nivolumab in combination with ipilimumab with close monitoring
either as a monotherapy or in combination with ipilimumab, should be continued as long as clinical benefit is observed
also in combination with ipilimumab.